Skip to main content

Anticholinergic Drugs to Avoid in the Elderly

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on March 15, 2024.

What are anticholinergic drugs?

Drugs with anticholinergic properties can be problematic, especially for the elderly. Anticholinergic drugs block (antagonize) the action of the neurotransmitter acetylcholine. A neurotransmitter is a chemical released by nerve cells to send signals to other cells. Acetylcholine is involved in transmitting messages that affect muscle contractions in the body and learning and memory in the brain.

Drugs with anticholinergic properties have been used in medicine for many decades in the treatment of such diverse conditions as:

Side Effects

Why should many anticholinergic drugs be avoided in the elderly? Chemical properties of these drugs can cause a wide array of side effects, some of which can be serious.

The central nervous system and the brain are very sensitive to anticholinergic side effects due to fewer cholinergic neurons or receptors in the brain of older individuals. In addition, the liver and kidney have less ability to break down and excrete medications. Also, drugs can cross more easily into the brain. All of these factors contribute to greater anticholinergic side effects in older adults.

Most commonly, anticholinergics can cause the following side effects:

Anticholinergic drugs fall into many different classes of drugs, so it’s hard for patients (and even providers) to identify or remember these specific drugs. For example, some antihistamines, antidepressants, or even muscle relaxants have anticholinergic properties. Patients with delirium, dementia, constipation, and benign prostatic hypertrophy (BPH) are particularly at risk of anticholinergic drug side effects.

View below for a suggested list of anticholinergic drugs to avoid in older patients.

Dementia Risk

Anticholinergic drugs should be avoided in patients with dementia, cognitive impairment, or delirium. A study published in JAMA Internal Medicine noted that higher cumulative anticholinergic medication use was associated with an increased risk for dementia.

Data in this study were evaluated from a prospective, population-based cohort study using data from the Adult Changes in Thought Study. Over 3,400 participants aged 65 and older with no dementia were enrolled at study entry between 1994 and 2003.

It was found the most common anticholinergic drug classes used by the elderly in the study were:

Overall, a higher overall use of anticholinergic medications (3 years or more) across all groups of patients was linked with a 54% higher risk for developing dementia than taking the same dose for three months or less. Results also suggested that the risk for dementia with anticholinergics remain even after drug discontinuation.

A case-control study published in 2019 in JAMA Internal Medicine also highlighted risk of dementia with long-term use of anticholinergics in persons 55 years or older.

Anticholinergic drugs should not be used in conditions such as:

Do not stop treatment without talking to your doctor. Patients and clinicians should avoid abruptly stopping long-term anticholinergic drugs, when possible, to minimize withdrawal symptoms. A slower taper may help to avoid side effects.

The Beers Criteria

As noted in the 2023 Beers Criteria, it is well established that many drugs with anticholinergic properties should be avoided in the elderly whenever possible.

List of Anticholinergic Drugs to Be Avoided in the Elderly

Many of the below drugs are found in over-the-counter (OTC) products or in combination with other medications (prescription or OTC). For example, multiple OTC sleep medications contain diphenhydramine (Benadryl), a sedating antihistamine with strong anticholinergic properties. Always check with your pharmacist or doctor if you are concerned about the use of anticholinergic drugs.

This is not a complete list of anticholinergic medications or the Beers Criteria, but includes many of the most common ones to avoid, when possible. Always check with your pharmacist or doctor if you are concerned about the use of anticholinergic drugs.

Note: Review the Beers Criteria 2023 for a full list of drugs to avoid in the elderly.

Antihistamines, First-Generation

* Use of diphenhydramine in acute allergic reactions may be appropriate. Many OTC sleep agents have diphenhydramine as an active ingredient, so be sure to check labels or ask your pharmacist.

Antiparkinsonian Agents*

* In general, these agents are not recommended for prevention of extrapyramidal symptoms with antipsychotics. In addition, more-effective agents are available for treatment of Parkinson disease, especially for older individuals.

Skeletal Muscle Relaxants

Note: the recommendation to avoid skeletal muscle relaxants does not apply to agents used for spasticity (such as baclofen and tizanidine), although these drugs may still be poorly tolerated.

Antiarrhythmics

Antidepressants

Antimuscarinics (Urinary Incontinence)

Antipsychotics1,2

1Boxed warnings exist about the use of antipsychotics in the elderly with dementia. Antipsychotics are not approved for use in psychotic conditions related to dementia. Antipsychotics may increase the risk of death in older adults with dementia-related conditions.

2 Strongly anticholinergic but may be appropriate in some situations (bipolar disorder, schizophrenia, short-term chemotherapy).

Antispasmodics

Antiemetics

Miscellaneous

See Also:

Sources

  • By the 2023 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023 Jul;71(7):2052-2081. doi: 10.1111/jgs.18372. 
  • Guideline update. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Select highlights for medications to avoid, adjust dosage for or use with caution. Drug Table 2023. https://www.guidelinecentral.com/guideline/340784/
  • Cojuc-Konigsberg G, Schoo C. Inappropriate Medication in the Geriatric Population. [Updated 2022 Nov 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK585118/
  • Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015;15:31. Published 2015 Mar 25. doi:10.1186/s12877-015-0029-9
  • Campbell N, Boustani M, Limbil T, et al. The Cognitive Impacts of Anticholinergics: A Clinical Review. Clin Interv Aging. 2009;4: 225–233.
  • Gray SL, Anderson ML, Dublin S et al. Cumulative use of strong anticholinergics and incident dementia: A prospective cohort study. JAMA Intern Med 2015;175:401–407. 
  • Merz B. Common anticholinergic drugs like Benadryl linked to increased dementia risk. Harvard Health Blog. September 10, 2015. Accessed March 15, 2024 at https://www.health.harvard.edu/blog/common-anticholinergic-drugs-like-benadryl-linked-increased-dementia-risk-201501287667
  • Coupland CA, Hill T, Dening T, et al. Anticholinergic Drug Exposure and the Risk of Dementia. A Nested Case-Control Study. JAMA Intern Med. Published online June 24, 2019. doi:10.1001/jamainternmed.2019.0677

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.